Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PT-150 by Palisades Therapeutics for Pancreatic Cancer: Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
PT-150 by Palisades Therapeutics for Alcohol Dependence: Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase II for Alcohol Dependence. According to GlobalData, Phase...
PT-150 by Palisades Therapeutics for Glioblastoma Multiforme (GBM): Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...
PT-150 by Palisades Therapeutics for Prostate Cancer: Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...
PT-150 by Palisades Therapeutics for Ovarian Cancer: Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...